Specifically, we found that ACAT1 acts as a potential mLSTase, which affected the Ksucc level of mitochondrial metabolism–related enzymes and enhanced the mitochondrial oxidative metabolism of NSCLC, subsequently blocking the formation of TLS in a ROS-dependent manner, and promoting tumor progression. This evidence concerns the gene ACAT1 and non-small cell lung carcinoma.